Medica Venture Partners
16
13M
9
0.62
2
0.44
7
- Stages of investment
- Areas of investment
Summary
In 1995 was created Medica Venture Partners, which is appeared as VC. The company was established in Asia in Israel. The main department of described VC is located in the Herzliya.
The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most popular portfolio startups of the fund, we may highlight Dynogen Pharmaceuticals, FlowMedica, InterCure. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular fund investment industries, there are Life Science, Medical.
The fund was created by Ehud Geller. We also calculated 4 valuable employees in our database.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Medica Venture Partners, startups are often financed by Oxford Bioscience Partners, True North Venture Partners, True North Partners. The meaningful sponsors for the fund in investment in the same round are Oxford Bioscience Partners, SCP Vitalife Partners, Pitango Venture Capital. In the next rounds fund is usually obtained by Oxford Bioscience Partners, SCP Vitalife Partners, OrbiMed.
The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2012. Comparing to the other companies, this Medica Venture Partners performs on 14 percentage points more the average number of lead investments. The top activity for fund was in 2003. Considering the real fund results, this VC is 6 percentage points less often commits exit comparing to other organizations.
Investments analytics
Analytics
- Total investments
- 16
- Lead investments
- 2
- Exits
- 7
- Rounds per year
- 0.62
- Follow on index
- 0.44
- Investments by industry
- Health Care (15)
- Medical Device (13)
- Medical (7)
- Manufacturing (4)
- Biotechnology (4) Show 5 more
- Investments by region
-
- United States (9)
- Israel (6)
- Germany (1)
- Peak activity year
- 2005
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 22
- Avg. valuation at time of investment
- 47M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 1.86
- Strategy success index
- 0.40
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| InterCure | 30 Oct 2001 | Health Care, Manufacturing, Medical Device, Therapeutics | Early Stage Venture | 4M | HaMerkaz, Ra'anana, Israel |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.